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Recent analyses suggest that the p24 capsid (p24CA) domain of the HIV-1 group-specific antigen (Gag) may be divided into
two structurally and functionally distinct moieties: (i) an amino-terminal portion, previously shown to bind the cellular
chaperone cyclophilin A, and (ii) a carboxy-terminal domain, known to contribute to the interaction of the Gag and Gag-Pol
precursors during the early assembly process. In order to gain deeper insight into the role of the amino-terminal domain of
the p24CA protein during viral replication, eight highly conserved proline residues known to promote turns and to terminate
a-helices within the p24 tertiary structure were replaced by a leucine residue (P-position-L). Following transfection of the
proviral constructs in COS7 cells, the majority of the mutants resembled wild-type viruses with respect to the assembly and
release of virions. However, although the released particles contained wild-type levels of genomic viral RNA, the mature
products of the Gag and Gag-Pol polyproteins as well as the Env glycoproteins—all of them, except mutant P225L—were
either noninfectious or severely affected in their replicative capacity. Entry assays monitoring the process of viral DNA
synthesis led to the classification of selected provirus mutants into four different phenotypes: (i) mutant P225L was infectious
and allowed complete reverse transcription including formation of 2-LTR circles; (ii) mutants P149L, P170L, and P217L failed
to form 2-LTR circles; (iii) mutant P222L displayed a severe defect in binding and incorporating cyclophilin A into virions, was
delayed with respect to DNA polymerization, and failed to form a 2-LTR replication intermediate; and (iv) mutant P133L was
unable even to synthesize a first-strand cDNA product. All replication-defective mutants were characterized by severe
alterations in the stability of virion cores, which were in two cases reflected by visible changes in the core morphology. These
results suggest that proline residues in the NH2-terminal capsid domain represent critical structure determinants for proper
formation of functional virion cores and subsequent stages of early replication. © 2000 Academic Press
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The HIV-1 group-specific antigens, like those of other
retroviruses (Wills and Craven, 1991), have been demon-
strated to be both necessary and sufficient to direct the
assembly and release of immature virus particles (Ghey-
sen et al., 1989; Haffar et al., 1990; Mergener et al., 1992;
agner et al., 1992). The internal structural proteins of
IV-1 are encoded by the gag gene and translated from
n unspliced RNA as a 55-kDa polyprotein precursor
Pr55gag). Ribosomal frameshifting into the pol frame,
hich occurs with a frequency of 5–10%, leads to the
ynthesis of a 160-kDa Gag-Pol (Pr160gag-pol) read-through
polyprotein (Kappes et al., 1988; Jacks et al., 1988). Co-
translational myristoylation of the Gag and Gag-Pol pro-
teins is required for the assembly of the precursor mol-
ecules underneath the cell membrane and subsequent
formation of spherical structures (Gottlinger et al., 1989;
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294elderblom, 1991) that are released from cells in a Vpu
acilitated manner (Klimkait et al., 1990; Gottlinger et al.,
993). During or shortly subsequent to particle release,
leavage by the viral protease yields the mature Gag
roducts p17MA, p24CA, p7NC, and p6, as well as the viral
nzymes protease (PR), reverse transcriptase (RT), and
ntegrase (IN) (Mervis et al., 1988; Henderson et al.,
992).
Previous reports from widely divergent retroviruses
uggested that the p24CA domain contains sequences
hat play a central role in particle assembly (Jones et al.,
990; Wills and Craven, 1991; Strambio de Castillia and
unter, 1992). In the case of HIV, distinct sequences
nvolved in Pr55gag assembly and Pr160gag-pol incorpora-
tion have been mapped to different regions within the
C-terminal 80 residues of p24CA (Chazal et al., 1994; von
Poblotzki et al., 1993; Hockley et al., 1994; Mammano et
l., 1994; Dorfman et al., 1994a; Huang and Martin, 1997).
onversely, it was shown for HIV-1 and Rous sarcoma
irus that extended sequences in the N-terminal portion
f the p24 domain within the Gag precursor are dispens-
ble for particle production (Weldon et al., 1990; Wagner
t al., 1994). However, deletions in this domain resulted
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295PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINin HIV particles that were completely noninfectious, sug-
gesting a role of the N-terminal portion of p24CA early in
he viral life cycle (Trono et al., 1989; Wang and Barklis,
993; Reicin et al., 1996; Dorfman et al., 1994a).
These observations are in agreement with very recent
iochemical and biophysical studies suggesting that the
24 capsid protein can be further separated into two func-
ionally and structurally distinct moieties: (i) a C-terminal
our-helix globular domain (Gamble et al., 1997; Gitti et al.,
996) mediating oligomerization of the Gag and Gag-Pol
recursor and (ii) a proline-rich N-terminal CA domain (aa
–151), which is composed of seven a-helices, two b-hair-
pins, and a solvent-exposed partially ordered loop (Gitti et
al., 1996; Gamble et al., 1996). For HIV-1, it has been dem-
onstrated that this loop mediates the virion incorporation of
cyclophilin A (CypA) (Luban et al., 1993; Franke et al., 1994;
Thali et al., 1994; Gamble et al., 1996), the major cytoplas-
mic member of a ubiquitous family of peptidyl-prolyl race-
mases (Fischer et al., 1989; Gething and Sambrook, 1992).
Remarkably, the Gag proteins of the closely related primate
lentiviruses SIV and HIV-2 do not bind CypA and these
viruses do not package CypA into virions (Franke et al.,
1994; Thali et al., 1992; Billich et al., 1995). The absence of
CypA in HIV-1 virions results in a block of viral replication at
an early stage of the viral life cycle (Thali et al., 1994;
Braaten et al., 1996; Steinkasserer et al., 1995). Additionally,
both structural and functional data suggest that protein
rearrangements after proteolytic maturation and formation
of a salt bridge between P1 and D51 within the mature
capsid (corresponding to P133 and D183 in Pr55gag) are
essential for proper core assembly and viral infectivity (Gitti
et al., 1996; Gross et al., 1998; von Schwedler et al., 1998).
According to the three-dimensional structure of the
24CA N-terminal core domain, proline residues termi-
ate a-helices and promote the partially ordered CypA
inding loop (Gitti et al., 1996; Gamble et al., 1996). In
rder to extend our knowledge of the structure–function
elationship of the N-terminal p24CA moiety, proline resi-
ues that are conserved among all HIV-1 clades includ-
ng subtype O were replaced by leucine residues. The
ffects of the mutations on viral morphogenesis and on
he replicative capacity of the mutant viruses were ana-
yzed. Most mutants displayed severe defects at different
tages of viral replication that correlated with alterations
n the viral core stability and in some cases with an
rregular morphology of the virion cores. These data
uggest a role of the NH2-terminal p24
CA domain during
he formation of functional virion cores and consecutive
arly stages of viral replication.
RESULTS
onstruction of substitution mutants
Each of seven proline residues within the amino-ter-
CAinal 99 amino acids of p24 was substituted for
leucine residues, either alone or in combination with a
a
lflanking proline residue(s) as shown in Fig. 1. These
proline residues are highly conserved among all known
HIV-1 clades including subtype O. For functional testing
in cell culture, full-length proviruses that differ from the
parental HX10 proviral clone only by the presence of the
indicated amino acid substitution(s) were reconstructed
by site-directed mutagenesis.
Expression of and assembly of HIV-1 proline
substitution mutants
To study the influence of the mutations on the assem-
bly process and particle production, CD42 COS7 cells
ere transfected with full-length wild-type (wt) or mutant
roviral DNAs, respectively. The expression of gag-en-
oded proteins and their release from transfected cells
ere monitored by immunoblot analysis from cell lysates
FIG. 1. Schematic drawing of proline substitution mutants. The po-
sition of the gag gene within the HIV-1 proviral genome is shown. The
mature cleavage products of the Pr55gag precursor as well as the
ositions of the substituted proline residues within the N-terminal core
omain of the p24 capsid protein (p24CA) are indicated. The nomencla-
ure of proline substitutions is listed at the right (P, proline; L, leucine;
he number in between gives the position of the substituted proline
esidue relative to the N-terminus of the Pr55gag polyprotein precursor).nd cell culture supernatants, using a mixture of se-
ected human antisera. This pool of antisera was se-
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296 FITZON ET AL.lected for its ability to recognize the Env glycoproteins
gp160/120, the Pr55gag precursor including partially pro-
essed Pr41gag, and the mature p24CA protein as well as
the mature cleavage products of the Pr160gag-pol protein
p66RT, p51RT, and p32IN.
Two days posttransfection, the unprocessed 55-kDa
Gag precursor including a Pr41gag cleavage intermediate
nd mature p24CA protein were readily detected in all
tested cell lysates (Fig. 2A). Typically for the analysis of
cell lysates, two variants of the capsid protein, p24CA and
25CA, were found, reflecting the cleavage of the precur-
or protein at two closely adjacent cleavage sites flank-
ng the spacer peptide SP1 (P2) adjacent to the C-termi-
FIG. 2. Viral protein expression, release, and composition of virus m
control, COS7 cells were transfected with the same amount of a pSP6
48 h posttransfection (A). The release and composition of mutant virions
from parallel transfections after 60 h and sedimented through a 30
subsequently separated by 12.5% SDS–PAGE and viral proteins were d
the molecular weight standards are indicated at the left. Specifically dus of the CA domain (Pettit et al., 1994; Krausslich et al.,
995; Wiegers et al., 1998). Additionally, the uncleavednvelope glycoprotein gp160 was recognized in all
ested cell lysates. In most cases, the levels of synthe-
ized mutant Gag products were comparable to those
btained from cells transfected with the parental DNA.
owever, significantly smaller amounts of viral Gag pro-
eins were noted in the lysates of P133-149L and P231L
s well as P217-231L transfected cells (Fig. 2A). In these
ases, quantitative analysis using a commercial p24 cap-
ure assay confirmed the reduction of cell-associated
ag proteins by a factor of 5 to 10. This suggests that the
imultaneous substitution of residues P133, P149, and
231 for leucine leads to a significant decrease in pro-
ein stability (data not shown).
CA
. 1 3 106 cells were transfected with the indicated proviral DNAs. For
DNA (mock). Viral protein expression was analyzed in cells harvested
determined from filtrated cell culture supernatants that were harvested
se cushion (B). Lysates of transfected cells and viral pellets were
by immunoblotting using well-characterized HIV patient sera. Sizes of
HIV proteins are labeled on the right.utants
vector
were
% sucroThe ability of the p24 mutants to assemble and
release virus particles was tested using wild-type and
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297PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINmutant particles harvested from supernatants of trans-
fected cells for immunoblot analysis (Fig. 2B). Unproc-
essed Pr55gag, a 41-kDa processing intermediate
Pr41gag), and the mature p24CA were specifically identi-
fied. In addition, mature cleavage products of the
Pr160gag-pol polyprotein (p24CA, p66RT, p51RT, and p32IN)
were found, indicating that the mutations in p24CA did not
impair the incorporation and processing of Pr160gag-pol
into the virions (Smith et al., 1990; Amadori et al., 1991;
Huang and Martin, 1997). Neither wild-type HIV nor any
of the mutants had evidence of p25. This demonstrated
regular cleavage at the p24 C-terminus leading to the
removal of SP1 (P2)—a process that has been previously
shown to be required for generating intact virion cores
and infectious particles (Krausslich et al., 1995; Wiegers
et al., 1998). Although viral particles released from wild-
type and P133L transfected cells included almost iden-
tical amounts of the 55-kDa Gag precursor, the pattern
as well as the molar ratio of P133L derived cleavage
products (p24 versus Pr55gag) was in some experiments
slightly altered compared to the parental virus. This find-
ing suggests that the proline to leucine substitution at
the P19 position within the p17/p24 cleavage site might
partially interfere with efficient processing. Although the
P166L mutation did not significantly affect the levels of
intracellular proteins synthesized and regardless of in-
corporating mature Pr55gag and Pr160gag-pol products into
articles, only minute amounts of virions were released
rom transfected cells (Figs. 2A and 2B). This finding was
onfirmed by exactly quantifying the levels of intracellu-
ar and virion-associated gag protein using a commercial
24 sandwich assay (data not shown). This suggests that
he P166L mutation negatively acts on the assembly
nd/or release of virions from cells rather than interfering
ith mRNA or protein stability. Interestingly, substitution
f P170L in addition to P166L (P166-170L) seemed to
artially compensate for the observed failure in particle
ormation of mutant P166L alone (Fig. 2B; data not
hown). Consistent with the amounts of intracellular viral
roteins shown in Fig. 2A, the levels of virion-associated
roteins observed in the case of mutants P133-149L,
231L, and P217-231L chiefly corresponded to the small
mounts of intracellular Gag protein, strongly suggesting
direct effect of these particular mutations on RNA or
rotein stability.
nfectivity of the mutant virions.
To assay the mutants for viral infectivity, permissive MT4
ells were infected with normalized amounts of wild-type
nd mutant viruses that were harvested and purified from
upernatants of transfected COS7 cells. None of the mu-
ants—except P225L—showed any sign of infectivity in
his MT4 cell-based long-term culture experiment (data not
hown). Mutant P225L replicated with kinetics similar to
hat of the parental virus, showing a p24 maximum at day
q
p–7 p.i. These observations were largely confirmed by an-
lyzing the very same virus preparations in a more sensitive
ingle-round replication assay using HeLa CD4-LTR/b-gal
cells as the indicator cell line (Table 1). In agreement with
the MT4 culture experiment, comparable titers of infectious
virus (expressed as number of blue cells) were found for
the parental construct and mutant P225L. However, in this
assay system, residual infectivity with an about 2 log re-
duction compared to the parental virus was reproducibly
found for the mutants P170L, P217L, and P222L. This sug-
gests for these mutants a severely delayed replication ki-
netics that might—under the selected assay conditions—
prevent virus spread in the MT4 culture to detectable levels.
Alternatively, in the case of P222L, the discrepancy be-
tween the results obtained in the applied assay systems
may also be explained by cell type-specific differences in
the intracellular levels of CypA that turned out to be respon-
sible for a residual infectivity of mutant P222A in CEM and
H9 cells, whereas the same mutant was completely nonin-
fectious in Jurkat cells (Kong et al., 1998; Ackerson et al.,
1998).
Incorporation of gp120 and viral genomic RNA into
mutant virus particles
Comparable to the wild-type situation, all mutant par-
ticles included gp120 envelope proteins in amounts cor-
relating with those of the detected Gag products (Fig.
2B). Thus, the mutations introduced into the capsid moi-
ety of the Gag precursor did not interfere with the p17MA
mediated incorporation of envelope proteins into nas-
cent virions (Dorfman et al., 1994b; Yu et al., 1992; Mam-
ano et al., 1995; Freed and Martin, 1995). Further anal-
sis, subjecting normalized amounts (RT activity) of wild-
ype and mutant viral particles to a b-DNA based
TABLE 1
Infectivity as Determined by Single-Round Infection Assay
Construct No. of blue focia
wt 1.4 3 103
P133L 0
P149L 0
P133/149L 0
P166L 0
P170L #5 3 101
P166/170L 0
P217L #5 3 101
P222L #5 3 101
P225L 1.2 3 103
P231L 0
P217/231L 0
a Values represent the average number of blue foci per nanogram of
24. Representative data from three experiments are presented.uantification of viral RNA, revealed that all of the tested
24CA mutants were able to package genomic RNA com-
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298 FITZON ET AL.parable to wild-type virions ranging from 4.7 6 1.5 3 106
RNA equivalents/7.7 3 10211 g p24 (wild-type 5.0 3 106
RNA equivalents/7.7 3 10211 g p24). Therefore, neither
the capacity of the mutants to incorporate envelope pro-
teins nor the packaging of viral RNA into virions explains
the severe alterations in viral infectivity.
Analysis of virus particle density, size, and shape
Further analysis on the molecular mechanisms ac-
counting for the described failure in viral infectivity con-
centrated on those mutants with so far no or only minor
defects during virus morphogenesis. For that purpose,
we first analyzed the biophysical properties of virus par-
ticles that were released from transfected COS7 cells by
FIG. 4. In vitro binding of the cellular chaperone cyclophilin A (CypA)
rotein that bound to a GST–CypA fusion construct was expressed as
values of three independent binding reactions. Standard deviations o
FIG. 3. Biophysical properties of released virus particles. Supernata
ndicated proviral plasmid DNAs. (A) The density of the virions was dete
t 120,000 g for 20 h. (B) The distribution in size of released virus part
radient at 20,000 g for 90 min. Twenty fractions were collected from
quantitative p24 sandwich ELISA. The density of each fraction is indicvirions. Incorporated CypA was detected by immunoblot analysis from purified
quantification of incorporated flag-tagged CypA as determined by PhosphoImmeans of sucrose density and velocity gradients. Com-
parable to the wild-type situation, most of the mutants
displayed a p24 maximum at a density of 1.16 to 1.17
g/cm3 in the equilibrium gradient, indicating no or only
inor effects of the proline substitutions on particle den-
ity (data not shown). By contrast, although displaying
ild-type-like density profiles, mutants P170L and P166-
70L significantly deviated in velocity gradients from the
ild-type virus and the remaining mutants (Figs. 3A and
B). Thus, particles derived from mutant P170L seem to
e significantly larger than wild-type virions or exhibit an
ltered shape, whereas mutant P166-170L rather showed
distribution over the whole range of the gradient with
low and fast sedimenting aggregates (Fig. 3B).
gag and incorporation into virions. (A) The amount of the indicated Gag
centage of adsorbed wild-type HIV-1 Pr55gag. Data represent the mean
eans are indicated. (B) Incorporation of flag-tagged CypA into HIV-1
ransfected COS7 cells were harvested 60 h posttransfection with the
by equilibrium density centrifugation on a 10 to 60% sucrose gradient
as analyzed by velocity gradient centrifugation on a 5 to 40% sucrose
p of each gradient and the distribution of p24 was analyzed using a
the right.to Pr55
the per
f the mnts of t
rmined
icles wvirions using a flag-specific monoclonal antibody. Bars represent the
ager.
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b
o
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299PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINIn vitro binding of the cellular chaperone cyclophilin A
to Pr55gag and incorporation into virions
Recently, it was clearly demonstrated that a block in
he binding capacity of Pr55gag mutants to CypA chiefly
correlates with the absence of cyclophilin A in the virus
particles and a loss in viral infectivity (Franke et al., 1994;
Thali et al., 1994; Braaten et al., 1996). Accordingly, the
capacity of wild-type and mutant Pr55gag to bind to a
recombinant GST–CypA fusion protein was determined
in vitro using a commercial p24 sandwich ELISA. The
wild-type HIV-1 Pr55gag precursor and all Pr55gag mutants
except P222L bound to a comparable extent to the GST–
CypA fusion protein (Fig. 4A), but not to irrelevant GST
derivatives. Compared to the wild-type Pr55gag precursor,
he CypA binding capacity of mutant P222L was reduced
y a factor of 10–20. Confirming previous results by
thers (Franke et al., 1994; Thali et al., 1992; Billich et al.,
995), the SIVmac239 derived Pr57
gag negative control pro-
tein did not bind to CypA. Consecutive immunoblot anal-
ysis using different HIV-1 p24- and SIV p27-specific
monoclonal antibodies to detect bound Gag polypep-
tides confirmed these results (data not shown). Cyclo-
philin A incorporation into purified virus particles was
assayed 60 h following cotransfection of a flag-tagged
cyclophilin A expression construct and the proviral DNAs
into COS7 cells. Virus particles were isolated from cell
culture supernatants by centrifugation through a sucrose
cushion and equal amounts of material were loaded in
the respective lanes. Virus-associated CypA was deter-
mined by Western blot analysis using a commercial flag-
specific murine monoclonal antibody. The amounts of
incorporated CypA were estimated by densitometric
analysis (Fig. 4B). Extending the in vitro binding studies,
all mutants except P222L incorporated CypA in amounts
that reproducibly paralleled those found in wild-type vi-
rus particles. The calculated amount of CypA detected in
particles of mutant P222L was at least 10- to 20-fold
reduced compared to wild-type virions (Fig. 4B). Trace
amounts of the flag–CypA fusion protein were regularly
detected in supernatants of cells that were mock-trans-
fected with the flag-CypA expression plasmid only. In
accordance with observations by others, this finding may
be explained by the secretion of vesicular structures
containing small amounts of CypA from transfected cells
into the supernatant (Bess et al., 1997). Although we
selected a different type of amino acid substitution, we
found in agreement with previous reports that P222 crit-
ically contributes to the binding of CypA. Thus, in the
case of P222L, the observed reduction in replicative
capacity may be due to a failure in packaging of CypA
into virions, although a direct effect of this mutation on
p24 capsid interactions cannot be excluded (Franke et
al., 1994; Braaten et al., 1996). Additionally, our data
confirm that proline residues flanking P222 within this
proline-rich domain (P217, P225) do not critically contrib-ute to CypA incorporation into virions (Franke et al.,
1994).
Analysis of early replication
To identify more precisely the step in the viral life cycle
affected by the mutations, viral DNA synthesis was stud-
ied in freshly infected MT4 cells. For that purpose, wild-
type and mutant virions harvested from the supernatant
of transfected COS7 cells were used to acutely infect
MT4 cells. At different intervals during and after infection,
the cells were harvested and total cellular DNA was
isolated. This DNA was then subjected to PCR analysis
using three different primer pairs to identify distinct rep-
lication intermediates as described previously (von
Schwedler et al., 1993).
Primers within the vif coding region amplified early
linear DNA intermediates of reverse transcription. Late
double-stranded linear intermediates, generated after
the second template switch, were monitored with prim-
ers overlapping the U5/gag junction and circular two-LTR
forms of viral DNA were monitored by a primer pair
spanning the U3/U5 junction. Closed circular forms of
the retroviral genome containing 1-LTR, or 2-LTRs are
found in the nuclei of infected cells only after the syn-
thesis of linear viral DNA and its transport into the nu-
cleus. Although these circular, covalently linked replica-
tion by-products are not preintegration precursors, the
amplification of the U3/U5 junction serves as a marker of
viral DNA synthesis and its transport to the nucleus,
which necessarily requires preceding disassembly of
viral core structures (Brown et al., 1989; 1987; von
Schwedler et al., 1993; Pauza et al., 1994). In addition,
since the U3/U5 junction does not exist in the plasmid
proviral DNA, the use of the selected primer pair ensures
that the amplified product is not representing input plas-
mid DNA. To further exclude contaminations of the virus
preparations by plasmid proviral DNAs, infected MT4
cells were subjected to a PCR, specifically binding to
proviral plasmid backbone. Only samples that were neg-
ative for plasmid DNA were processed for further PCR
analysis.
In complete agreement with the long-term infection
experiment, 2-LTR products could be amplified exclu-
sively from T-cells that were infected with the wild-type
virus and mutant P225L (Fig. 5). This suggested that the
remainder of the mutants displayed a defect during ear-
lier stages of replication. DNA isolated from P133L and
P166-170L infected cells completely failed to amplify a vif
product, indicating a defect in the initiation of reverse
transcription or after strong stop DNA synthesis. As dem-
onstrated by the amplification of the vif and the U5/gag
products, the remainder of the mutants (P149L, P170L,
P217L, and P222L) were able to synthesize almost com-
plete double-stranded DNA intermediates to a compara-
ble extent, except mutant P222L, for which the second-
aration
300 FITZON ET AL.strand DNA synthesis was reproducibly delayed. How-
ever, despite the synthesis of almost complete linear
replication intermediates, these mutants failed to sup-
port the amplification of the 2-LTR intermediate, suggest-
ing major defects at earlier stages such as a failure in
proper core assembly or alterations in core stability.
EM analysis of mutants
To further examine the effect of the proline substitu-
tions on virion size and morphology, ultrathin-section
electron microscopy analysis of COS7 cells transfected
FIG. 5. Comparison of various reverse transcription intermediates p
with a m.o.i. 5 1 of the indicated proline substitution mutants. The occu
time points using primers specific for intermediates of reverse transcr
circle). The intermediates of viral replication were visualized by sep
amplification products using digoxygenin-labeled probes.FIG. 6. Electron micrographs of wild-type (A) and CA mutant Hwith wild-type and mutant HX10 provirus constructs was
performed. The sizes of wild-type particles varied be-
tween 85 and 120 nm. Mature wild-type viruses dis-
played an electron-dense, cone-shaped or round core,
depending on the plane of sectioning (Fig. 6A). Regular
mature virions of normal size containing cone-shaped
electron-dense capsids were readily observed for mu-
tants P149L, P217L, P222L, and P225L. By contrast, sig-
nificant morphological alterations were observed for mu-
tants P170L and P133L. Many extracellular virions con-
taining condensed electron-dense structures were
in T cells after infection with mutant viruses. MT4 cells were infected
of different replication intermediates was analyzed by PCR at different
Vif, LTRU5-Gag) and completed reverse-transcription products (2-LTR
of the PCR products on an agarose gel, prior to detection of theresent
rrence
iption (IV-1 virions (B, C). Scale bars are 100 nm in all panels.
l
A
c
l t the m
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301PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINobserved for both mutants. Mutant P133L was charac-
terized by compact, predominantly round and acentric
core-like structures exhibiting an increased staining and
irregular condensation. In the case of mutant P170L,
cores were round and acentric and displayed a reduced
electron density compared to the core structures readily
found in wild-type virions or mutant P133L. Diameters of
P170L derived virus particles varied from 85 to 160 nm
(Figs. 6B and 6C).
Effect of mutations on core stability
To analyze alterations in mutant capsid stabilities,
wild-type and mutant particles were centrifuged
through a layer of sucrose either containing or lacking
detergent. Due to the brief contact time of the particles
with the detergent, this procedure has been demon-
strated to be moderately destabilizing and allows for
analysis of subtle modifications in capsid stability.
Amounts of pelletable cores were visualized by West-
ern blot analysis (Fig. 7A) and the percentage of pel-
letable capsid antigens after treatment compared to
untreated controls was calculated by densitometric
analysis (Fig. 7C). Approximately 20 to 30% of capsid
FIG. 7. Influence of the indicated amino acid substitutions on the sta
ayer of sucrose either containing or lacking detergent (A, C). Alternat
mounts of pelletable cores were visualized by Western blot analysis u
apsid antigens after treatment (1), compared to untreated controls (2
ight units with a PhosphoImager (C, D). The depicted data represen
eviations of the means are indicated.protein remained as a stable complex after centrifu-
gation of wild-type HIV-1 through a detergent layer(Figs. 7A and 7C). All mutants except P170L exhibited
a moderately to substantially increased core stability
ranging from 40 to more than 90% pelletable capsid
protein compared to the parental HIV-1 virions (30%).
For mutant P170L, however, no p24CA reactive material
was observed in the pellet fraction after detergent
treatment, suggesting that these capsids were com-
pletely solubilized and were significantly less stable
than wild-type capsids.
These results were extended by subjecting wild-type
and mutant particles to brief detergent treatment prior to
centrifugation. Due to the increased stringency of this
assay format, wild-type and P170L derived capsids were
completely solubilized. By contrast, the remainder of the
capsid mutations were confirmed to increase the stabil-
ity of the virion cores (Figs. 7B and 7D).
DISCUSSION
Among 11 established proline to leucine substitutions
within the N-terminal proline-rich region of the HIV-1 p24
capsid protein (Fig. 1), only mutant P225L replicated in
cell culture at levels comparable to wild-type levels. P225
is located at the (i 1 1) position of a type II turn within the
f viral cores. Virus particles were collected and centrifuged through a
rions were briefly treated with detergent prior to centrifugation (B, D).
p24-specific monoclonal antibody (A, B). The percentage of pelletable
independently calculated for each mutant by determining the relative
ean values of three independent transfection experiments. Standardbility o
ively, vi
sing a
), wascyclophilin A binding loop and can be mutated to leucine
without affecting CypA packaging or infectivity. Thus, by
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result confirms previous reports suggesting that P225 is
not critically involved in CypA binding and virion infectiv-
ity (Franke et al., 1994; Gitti et al., 1996).
Only mutant P166L breaking helix-2 within the N-ter-
minal p24 capsid domain displayed a significant defect
in the early assembly process with wild-type-like
amounts of cell-associated Gag protein and only minute
amounts (,10%) of released virus particles (Fig. 2). Given
the small amounts of cell-associated Gag protein for
mutant P133-149L, P231L, and P217-231L, the failure of
these provirus constructs to produce significant levels of
virus particles is rather due to a reduced protein stability
or translation efficiency than to a defect in Gag assembly
or particle release.
The remainder of the mutants turned out to be either
completely noninfectious or severely affected in their
replicative capacity although biochemical analysis re-
vealed no or only minor alterations in particle assembly
and release. Defects in any step subsequent to particle
release will be manifested at the time of virus entry
unless there are obvious morphological alterations.
Therefore, we performed a PCR-based entry assay,
which enabled us to monitor proviral DNA synthesis
during early stages of viral replication. In this assay,
mutant P133L displayed severe defects already during
the initial stages of reverse transcription, although the in
vitro RT activity was not affected by the mutation (data
not shown). As evidenced from previously described
mutants completely blocking the p17MA/p24CA cleavage
site (Gottlinger et al., 1989), even slight changes in the
pattern and ratio of Gag cleavage products, which are
due to the alteration of the P19 position of the p17MA/
24CA cleavage site (Partin et al., 1990), may account for
the observed deviations in condensation and location of
core-like structures. Alternatively, substituting the N-ter-
minal proline residue within the amino-terminal p24 cap-
sid domain might sterically prevent proper formation of a
salt bridge between the primary imino group of P133 and
the carboxyl group of D183 that stabilizes a-helices-1
and -2 via an amino-terminal b-hairpin (Gitti et al., 1996;
omany et al., 1996; von Schwedler et al., 1998). Free
ccessibility of the N-terminal proline residue has been
uggested (Gitti et al., 1996) and experimentally proven
y in vitro assembly studies to be required for the for-
ation of regular or tube-like core structures (Gross et
l., 1998). Both interpretations are supported by our
ransmission EM analysis, clearly demonstrating a de-
ect in core assembly with exclusively found electron-
ense, round and acentric structures (Fig. 6). This sug-
ests that the failure in early reverse transcription might
e closely related to the observed inability of the mature
apsid proteins to rearrange into functional cores (Figs.
and 7). Furthermore, our results are also in agreement
ith recent data obtained for vif-negative virus mutants,
or which nonhomogeneous packaging of the corehiefly correlated with the absence of reverse transcrip-
ion (Hoglund et al., 1994; Camaur and Trono, 1996).
In accordance with previous reports describing the
effect of substituting proline 222 within the cyclophilin A
binding loop by alanine (Franke et al., 1994; Braaten et
al., 1996; Steinkasserer et al., 1995), the proline to leucine
mutation prevented binding of CypA to the Gag precursor
in vitro. In agreement with this observation, the incorpo-
ration of cyclophilin A into virus particles was reduced
10- to 20-fold compared to the parental virus (Fig. 4),
rendering the released virions either noninfectious in
MT4 cells or severely reducing infectivity by 2 logs in the
single-round replication assay (Table 1). Complete or
partial blockage has been reported by others to occur
either prior to reverse transcription (Braaten et al., 1996)
or after cDNA synthesis (Steinkasserer et al., 1995). In
the case of mutant P222L we have reproducibly seen a
delay in complete cDNA synthesis followed by a failure
to detect 2-LTR intermediates (Fig. 5). This finding corre-
lated with a significant increase in core stability, clearly
contrasting a recent observation by others reporting a
wild-type-like phenotype for the very same mutant (Wieg-
ers et al., 1999). However, the assay applied in the latter
study primarily detects decreased core stabilities and
might therefore underscore stabilizing effects of the mu-
tation on viral cores. Based on these observations, one
might speculate that the lack of 2-LTR intermediates may
reflect alterations in the disassembly process. Although
a direct effect of the P222L mutation on the p24 capsid
interaction cannot be ruled out on the basis of the ex-
periments performed, the observed phenotype may be
explained by a defect in CypA incorporation. This inter-
pretation would also be in agreement with the currently
discussed models on the role of CypA during HIV repli-
cation, suggesting that CypA acts as a spacer either
weakening the association between highly ordered cap-
sid strips or promoting ordered assembly of virion cores,
both of which might facilitate the disassembly of the viral
cores (Gamble et al., 1996; Wiegers et al., 1999).
A similar phenotype has been displayed by the mu-
tants P149L, P170L, and P217L. However, although these
virions readily incorporated CypA at levels comparable
to the wild-type HIV-1 (Fig. 4), they were noninfectious on
MT4 cells and characterized by a replication arrest after
completion of the DNA synthesis in the same cell line.
Similar observations have been made after linker inser-
tions into the N-terminal p24CA domain. However, in
hese cases, the failure to generate 2-LTR intermediates
trictly correlated with severe alterations in the core
orphology similar to that observed for mutant P170L or
133L (Reicin et al., 1996). For comparison, despite
touching key positions within the N-terminal capsid do-
main with P149 breaking helix-1 and P217 stabilizing the
CypA binding loop, these mutants showed—within the
limits of the applied method—no obvious deviations in
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303PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINthe density, structure, and localization of the cores com-
pared to wild-type HIV.
Of course, this does not necessarily indicate that
there are no subtle conformational changes that might
result in minimal alterations in the core structures
being undetectable by ultrathin-section electron mi-
croscopy. Accordingly, P149L and P217L mutations
rendered virion cores more stable upon detergent
treatment. As for mutant P222L, the observed failure in
2-LTR formation might be explained by a functional
defect in the assembly and/or subsequent disassem-
bly of viral cores. However, the example of P170L,
exhibiting an altered core morphology in addition to a
decreased core stability, clearly demonstrates that ad-
ditional factors such as proper sequestration of viral
and/or cellular compounds into viral cores may criti-
cally influence the formation of 2-LTR intermediates
and subsequent steps of viral replication.
In summary, this study considerably extends previous
work demonstrating that the N-terminal portion of the
p24 capsid protein critically contributes to the formation
of functional virus cores (Wang et al., 1994; Reicin et al.,
1996; von Schwedler et al., 1998). Our data suggest that
even subtle alterations in the core formation result in
various defects in consecutive steps of early virus repli-
cation. Moreover, this study demonstrates that the ana-
lyzed proline residues represent critical structure deter-
minants for the formation of functional viral cores. Finally,
our observations underscore the dual and intrinsic func-
tion of the p24 capsid moiety (i) to direct the assembly of
mature capsid proteins into intact virion cores and (ii) to
mediate regular disassembly of these structures during
early steps of infection. However, the molecular mecha-
nisms triggering the assembly/disassembly process are
far from being completely clear and need to be further
evaluated.
MATERIALS AND METHODS
Recombinant DNAs. A pUC8 derivative, plin8Pr55
(Wagner et al., 1993), including the complete gag gene of
the parental HX10 proviral construct (Ratner et al., 1985)
was used as a template to generate the p24 capsid
mutations shown in Fig. 1. Mutagenesis was performed
by applying the QuickChange site-directed mutagenesis
kit (Stratagene, Heidelberg, Germany) on the double-
stranded DNA template according to the manufacturer’s
instructions. After subcloning of the 670-bp ClaI–SpeI
fragments into the ClaI–SpeI digested parental HX10
provirus DNA, the complete Gag coding sequence was
verified by Taq cycle sequencing (Applied Biosystems,
Weiterstadt, Germany). The numbering of the exchanged
amino acid (proline-position-leucine) refers to the N-
terminus of the complete gag gene. mCells, transfections, and infections
COS7 and H1299 cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% heat-
inactivated fetal calf serum, 100 U of penicillin per milli-
liter, 100 mg of streptomycin per milliliter, and 2 mM
lutamine. CEM4 and MT4 cells were obtained from the
merican Type Culture Collection (Rockville, MD) and
rown in RPMI 1640 medium supplemented as de-
cribed above.
Transfections of recombinant provirus plasmids into
OS7 cells were performed by the Ca(PO4)2 technique
Chen and Okayama, 1987). Sixty hours posttransfection
he culture supernatants were harvested and filtered
hrough a 0.45-mm-pore-size nitrocellulose filter (Schlei-
her and Schuell, Dassel, Germany). Virus particles were
oncentrated by centrifugation through a 30% (wt/wt)
ucrose cushion in STE at 4°C for 2 h at 120,000 g. The
viral pellet was resuspended by incubation overnight at
4°C in 200 ml RPMI 1640. The samples were normalized
or p24 and/or RT activity as described above. Viral in-
ectivity in a 4-week culture experiment was determined
n 5 3 106 MT4 cells after infection with a virus equiv-
lent of 25 ng of p24 (corresponding to 5 3 105 infectious
nits of the parental virus titrated on MT4 cells). Cells
ere split every 2 to 3 days and the content of virus was
etermined from supernatants using a commercial p24
andwich assay. For analysis of replication intermedi-
tes, virus containing supernatants were treated at 37°C
or 30 min with 70 U of DNase I (Promega, Heidelberg,
ermany) in the presence of 10 mM MgCl2 and incu-
bated for 30 min at 4°C with 5 3 106 MT4 cells in 2 ml of
medium containing polybrene (0.8 mg/ml). The samples
ere then diluted 10-fold with fresh medium.
ingle-round infection assay
Viral infectivity in a single-round infection assay (Magi
ssay) was quantified in HeLa CD4-LTR/b-gal cells as
described previously (Kimpton and Emerman, 1992).
Briefly, Magi cells carry the b-galactosidase gene under
the control of the HIV-1 long terminal repeat that is
activated by Tat protein synthesized from the infecting
virus. Thus, infected cells express b-galactosidase and
stain blue with X-Gal. Infected cells were counted after
60 h, with the infectivity reported as the number of blue
cells per nanogram of p24 of input virus.
Monitoring of replication intermediates
To closely follow virus replication during the early
stages of infection, viruses purified from supernatants of
transfected COS7 cells were allowed to adsorb to 5 3
106 MT4 cells in a volume of 2 ml at 4°C for 30 min
followed by another incubation period of 90 min at 37°C
6(1 mg p24/5 3 10 MT4 cells). After addition of fresh
edium, aliquots of 6 3 105 MT4 cells were taken at
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304 FITZON ET AL.different time points, washed to remove extracellular
virus, lysed in PCR lysis buffer, and subjected to PCR
analysis as described previously (von Schwedler et al.,
1993). The sequences of HIV-specific primers are as
follows (positions of nucleotides in HIV-1HXB2 (Ratner et
l., 1985) are indicated in parentheses): vifV, 59-GGG AAA
CT AGG GGA TGG TTT TAT (5136–5159); vifR, 59-CAG
GT CTA CTT GTG TGC TAT TC (5340–5317); LTRU5,
9-GGC TAA CTA GGG AAC CCA CTG CTT (496–516);
ag, 59-CCG AGT CCT GCG TCG AGA GAG C (698–677);
TR9, 59-GCC TCA ATA AAG CTT GCC TTG (522–542 and
606–9626); and LTR8, 59-TCC CAG GCT CAG ATC TGG
CT ACC (488–465 and 9572–9549). VifV and VifR amplify
longated minus-strand DNA, LTRU5 in combination with
ag amplifies double-stranded molecules generated af-
er the second template switch, and LTR9 together with
TR8 amplifies 2-LTR circles. Aliquots of the PCR prod-
cts were subjected to gel electrophoresis, transferred
o a nylon membrane, and probed with specific digoxy-
enin-labeled probes.
nalysis of transfected cells and composition of virus
articles
COS7 cells transfected with the various proviral con-
tructs were harvested 48 h after transfection, washed to
emove extracellular virus, and resuspended in a mini-
al volume of STE (0.1 M NaCl, 0.05 M Tris–HCl, pH 7.5,
mM EDTA). Extracellular particles released from COS7
ells were collected 60 h posttransfection from pre-
leared medium (10 min at 200 g) by centrifugation
hrough a 2-ml cushion of 30% (wt/wt) sucrose in STE at
20,000 g for 90 min at 4°C. Pellets were resuspended in
TE at 4°C overnight. Cell-associated Gag protein as
ell as cell-free viral particles were quantified by using a
ommercial p24 sandwich ELISA. Additionally, the
mount of virus particles released was measured by
etermining the RT activity as described above. For pro-
ein analysis, both transfected cells and particle extracts
ere resuspended in an appropriate volume of 20 mM
ris–HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA and char-
cterized by conventional Western blot analysis follow-
ng separation of the proteins on a 12.5% denaturating
odium dodecyl sulfate (SDS)–polyacrylamide gel. Viral
roteins were detected using a preselected pool of hu-
an HIV-specific antisera. The amount of RNA incorpo-
ated was quantified for each mutant by subjecting nor-
alized amounts of purified virions (according to RT
ctivity) to the b-DNA assay (Chiron Diagnostics, Ham-
urg, Germany).
iophysical analysis and detergent treatment of virus
articles
For equilibrium density gradients, normalized amounts
f purified virus particles were layered on top of contin-
ous sucrose gradients [10 to 60% (wt/wt) sucrose in
D
ATE]. Gradients were centrifuged for 20 h at 120,000 g at
°C. For velocity gradients, purified virions were layered
n 5 to 40% sucrose gradients and centrifuged for 90 min
t 120,000 g at 4°C. Twenty fractions (0.5 ml each) were
ollected from the top of the gradients and analyzed for
24CA protein content using a commercial p24 sandwich
ELISA and controlled by determining RT activity.
Detergent treatment of virus particles was performed
essentially as described by Wiegers et al. (1998). Briefly,
cell culture medium from transfected H1299 cells was
divided into two aliquots, one of which was treated with
0.5% Triton X-100 for 10 min at 37°C. Detergent-treated
and untreated samples were subsequently layered over
a cushion of 20% (wt/wt) sucrose in PBS and centrifuged
at 120,000 g for 2 h at 4°C. Alternatively, cleared culture
medium from transfected cells was centrifuged through
preformed step gradients containing a cushion of 20%
(wt/wt) sucrose and a 1-ml layer of 10% sucrose with or
without 0.5% Triton X-100. Centrifugation was performed
at 120,000 g for 2 h at 4°C. The pellets from both sets of
experiments were resuspended in PBS and analyzed by
Western blotting. p24 capsid protein was detected by a
monoclonal p24-specific antibody followed by an en-
hanced chemoluminiscence reaction (Supersignal Ultra,
Pierce, Rockford, IL). Bands were quantified with a Phos-
phoImager (Boehringer Mannheim, Mannheim, Ger-
many) and background values were subtracted from
each band.
Virion incorporation and in vitro binding of CypA to
Pr55gag
SIVmac239 Pr57
gag, wt-Pr55gag, and Pr55gag CA mutants
(Fig. 1) were expressed in Escherichia coli strain DH5a
following induction with 2 mM isopropyl-b-thiogalactopy-
anoside (Sambrook et al., 1989). Bacteria were pelleted
h after induction, washed in TEK buffer (20 mM Tris–
Cl, pH 7.5, 1 mM EDTA, and 100 mM KCl), and resus-
ended in lysis buffer (10 mM Tris–HCl, pH 7.5, 100 mM
Cl, 1 mM EDTA, 5 mM dithiothreitol, 1 mM phenylmeth-
lsulfonyl fluoride, 0.5% Nonidet-P40). The resuspended
acteria were frozen and thawed six times and sonicated
n ice for 30 s with a Labsonic-U sonifier (B. Braun,
elsungen, Germany) at an input setting of 1 with a 30%
uty cycle. Insoluble material was pelleted at 4°C for 10
in in a Beckman TL-100 ultracentrifuge. Total protein
as determined by the Bradford dye binding procedure
Bio-Rad, Munich, Germany). Supernatants were ad-
usted to 20% glycerol and stored at 270°C. Typical
inding reactions used crude bacterial lysates in a total
olume of 200 mg of binding buffer containing normalized
amounts of Pr55gag (2 mg determined by p24 sandwich
LISA; approximately 0.2 mM) and 5 mg of purified GST–
ypA or GST (approximately 0.5 mM; kindly provided by
r. Andreas Billich, Sandoz Research Institute, Vienna,
ustria). After incubation at 4°C on a rotator (GFL, Burg-
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305PROLINE RESIDUES IN HIV-1 NH2-TERMINAL CAPSID DOMAINwedel, Germany) 25 ml of 50% (v/v) pretreated glutathione
beads [G-beads (Pharmacia, Freiburg, Germany)] in
binding buffer was added and incubated for another 30
min. The G-beads were washed three times with 400 ml
f binding buffer and either directly subjected to a p24
andwich ELISA or subjected to immunoblot analysis.
yclophilin A incorporation into virus particles was ana-
yzed by cotransfecting an NH2-terminally Asp-Tyr-Lys-
Asp-flagged cyclophilin A expression construct (pcDNA-
CypA; kindly provided by Dr. Dobner, University of Re-
gensburg) together with the mutant provirus DNA into
COS7 cells. Virus particles were harvested and purified
by ultracentrifugation as described above. Particle-asso-
ciated cyclophilin A was determined by Western blot
analysis using a commercial flag-specific murine mono-
clonal antibody (Kodac, Germany).
Transmission electron microscopy
The virus-containing supernatants of transfected
COS7 cells were fixed with freshly made 2.5% glutaral-
dehyde in cacodylate buffer (0.13 M sodium cacodylate,
pH 7.3, 35 mM sucrose, 4 mM CaCl2) and 20% fetal calf
serum. After centrifugation (20,000 g, 3.5 h, 4°C), the
irus pellets were overlaid with 2% agar, postfixed in 1%
smium tetroxide (diluted in cacodylate buffer), and em-
edded after dehydration in EmBed-812 epoxy resin.
ections (70 to 80 nm thick) were stained as described
ith uranyl acetate and lead citrate (Reynolds, 1963). The
irus mutants were analyzed with a Zeiss-902 electron
icroscope at operating 80 kV.
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